Publication:
Changes in the Epidemiology of Diabetic Retinopathy in Spain: A Systematic Review and Meta-Analysis.

dc.contributor.authorRomero-Aroca, Pedro
dc.contributor.authorLópez-Galvez, Maribel
dc.contributor.authorMartinez-Brocca, Maria Asuncion
dc.contributor.authorPareja-Ríos, Alicia
dc.contributor.authorArtola, Sara
dc.contributor.authorFranch-Nadal, Josep
dc.contributor.authorFernandez-Ballart, Joan
dc.contributor.authorAndonegui, José
dc.contributor.authorBaget-Bernaldiz, Marc
dc.date.accessioned2023-05-03T13:54:32Z
dc.date.available2023-05-03T13:54:32Z
dc.date.issued2022-07-16
dc.description.abstractThe aim of the present study was to determine the prevalence and incidence of diabetic retinopathy (DR) and its changes in the last 20 years in type 2 diabetes mellitus (T2DM) patients in Spain. A systematic review with a meta-analysis was carried out on the studies published between 2001-2020 on the prevalence and incidence of DR and sight-threatening diabetic retinopathy (STDR) in Spain. The articles included were selected from four databases and publications of the Spanish Ministry of Health and Regional Health Care System (RHCS). The meta-analysis to determine heterogeneity and bias between studies was carried out with the MetaXL 4.0. Since 2001, we have observed an increase in the detection of patients with DM, and at the same time, screening programs for RD have been launched; thus, we can deduce that the increase in the detection of patients with DM, many of them in the initial phases, far exceeds the increased detection of patients with DR. The prevalence of DR was higher between 2001 and 2008 with values of 28.85%. These values decreased over the following period between 2009 and 2020 with a mean of 15.28%. Similarly the STDR prevalence decrease from 3.67% to 1.92% after 2008. The analysis of the longitudinal studies determined that the annual DR incidence was 3.83%, and the STDR annual incidence was 0.41%. In Spain, for T2DM, the current prevalence of DR is 15.28% and 1.92% forSTDR. The annual incidence of DR is 3.83% and is 0.41% for STDR.
dc.identifier.doi10.3390/healthcare10071318
dc.identifier.issn2227-9032
dc.identifier.pmcPMC9320037
dc.identifier.pmid35885844
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320037/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2227-9032/10/7/1318/pdf?version=1657955986
dc.identifier.urihttp://hdl.handle.net/10668/20998
dc.issue.number7
dc.journal.titleHealthcare (Basel, Switzerland)
dc.journal.titleabbreviationHealthcare (Basel)
dc.language.isoen
dc.organizationConsejería de Salud de la Junta de Andalucía
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectdiabetes mellitus
dc.subjectdiabetic retinopathy incidence
dc.subjectdiabetic retinopathy prevalence
dc.subjectepidemiology
dc.subjectmeta-analysis
dc.subjectscreening
dc.subjectsystematic review
dc.titleChanges in the Epidemiology of Diabetic Retinopathy in Spain: A Systematic Review and Meta-Analysis.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number10
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9320037.pdf
Size:
976.49 KB
Format:
Adobe Portable Document Format